跳至主要内容
临床试验/NCT03453320
NCT03453320已完成4 期

Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects

University Hospital, Linkoeping1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2018年2月24日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
12
试验地点
1
主要终点
Plasma volume

研究概览

简要总结

Treatment with colloidal solutions has during long time been a cornerstone within intensive care. Lately there has been a shift from synthetic colloids to natural albumine.

One of these solutions is the hyperoncotic "Albumin 20%". There are however still several aspects of the physiological effects of hyperoncotic albumin, that are not known.

In this study the main object is to study with what rate hyperoncotic albumin should be administered. Rapidly 30 minutes or slower 120 minutes.

详细描述

Difference in volume expansion as well as fluid recruitment from the tissues depending on infusion rate is of interest.

Plasma volume expansion is measured using hemoglobin as a marker and fluid recruitment of tissue fluid is measured as a combination of plasma volume expansion and urinary output.

Healthy individuals are asked to refrain from eating and drinking the night before the study. Two hours before study start, the subjects may take a sandwich and a glas to drink.

After 15 minutes of rest baseline blood samples are taken. Subjects are randomised to receive two rates of albumin solution (Albumin 20%) 3 ml/kg bodyweight at two separate occasions. Once with an infusion time of 30 minutes, once with an infusion time of 120 minutes. Between the two infusions there will be an interval of 3 to 20 weeks. Randomization is performed to chose which rate the subjects start with. 6 in each Group (total 12).

During each occasion15 blood samples are collected, during a 6 hour period. Hemoglobin, plasma Sodium, colloid osmotic pressure and albumin are analysed. The total volume of blood collected will be 170 ml at each occasion when an albumin infusion is given.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy, without allergies and with the age 18 years or above

排除标准

  • Heart failure
  • Signs of kidney injury/failure
  • Severe allergies
  • Pregnancy

研究组 & 干预措施

Rapid - Slow

Experimental

Two infusions of 3 ml/kg bodyweight of hyperoncotic albumin 20%, with an interval of 3 to 20 weeks between.

First time rapid (30 minutes), second time slow (120 minutes). Albumin solution

干预措施: Albumin solution (Drug)

Slow - Rapid

Experimental

Two infusions of 3 ml/kg bodyweight of hyperoncotic albumin 20%, with an interval of 3 to 20 weeks between.

First time rapid (120 minutes), second time slow (30 minutes). Albumin solution

干预措施: Albumin solution (Drug)

结局指标

主要结局

Plasma volume

时间窗: 6 hours

Albumin infusion expands the plasma volume and dilutes hemoglobin. The dilution of hemoglobin can be measured and is used to calculate the degree of plasma expansion.

次要结局

  • Colloid osmotic pressure(6 hours)
  • Fluid recruitment from tissues(6 hours)

研究者

发起方
University Hospital, Linkoeping
申办方类型
Other
责任方
Principal Investigator
主要研究者

Joachim Zdolsek

MD, PhD, Assoc prof, consultant

University Hospital, Linkoeping

研究点 (1)

Loading locations...

相似试验